Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.

Liam Townsend,Gerry Hughes,Colm Kerr,Mary Kelly,Roisin O'Connor, Eileen Sweeney,Catriona Doyle,Ruth O'Riordan,Colm Bergin,Ciaran Bannan

JAC-antimicrobial resistance（2020）

引用 54|浏览9

暂无评分

摘要

The rate of bacterial coinfection in SARS-CoV-2 is low. Despite this, prolonged courses of antimicrobial therapy were prescribed in our cohort. We recommend active antimicrobial stewardship in COVID-19 cases to ensure appropriate antimicrobial prescribing.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要